Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors
Emer Cooke, executive director of the EMA, said: We need to step up actions now industry, regulators, healthcare professionals, patients and the public at large all have a role to play in resolving these shortages and we are appealing to everyone to play their part. In June 2023, the UK government declared a national shortage of GLP-1 RAs for type 2 diabetes mellitus until 2024, attributing the shortages to an increase in demand for these products for licensed and off-label indications
The fix isnt avoiding stopping, its planning the transition: a slow taper, continued strength training, and a defined nutrition plan
GLP-1 medications significantly reduce appetite, which can lead to inadequate protein intake